Skip to main content
Clinical Trials/NCT01436760
NCT01436760
Completed
Not Applicable

Genetic Contribution of Pain and Inflammation in Irritable Bowel Syndrome.

University of Florida1 site in 1 country72 target enrollmentMay 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Irritable Bowel Syndrome
Sponsor
University of Florida
Enrollment
72
Locations
1
Primary Endpoint
Polymorphisms
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The goal of the study is to identify possible polymorphisms on the loci of candidate genes that may be involved in modulation of pain and inflammation in irritable bowel syndrome.

Detailed Description

Stored and de-linked blood or DNA from subjects with IBS will be utilized for analysis for possible polymorphisms at predetermined genetic loci located in chosen genes.

Registry
clinicaltrials.gov
Start Date
May 2011
End Date
March 2012
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects with IBS and previously stored samples

Exclusion Criteria

  • Subjects without IBS and no previously stored samples

Outcomes

Primary Outcomes

Polymorphisms

Time Frame: one year

The goal of the study isd to identify possible polymorphisms on the loci of canidate genes that may be involved in modulation of pain and inflammation in irritable Bowel Syndrome.

Study Sites (1)

Loading locations...

Similar Trials